Safety and efficacy of mycophenolate mofetil in pediatric renal transplantation.
Completed
- Registration Number
- NL-OMON29296
- Lead Sponsor
- /A
- Brief Summary
Transplantation. 2007 Apr 27;83(8):1041-7.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
All Dutch children, receiving a first kidney transplant after 01-01-2000, treated with initial immunosuppression corticosteroids, MMF and CsA, during the latter part of the study with addition of basiliximab.
Exclusion Criteria
1. Not on triple therapy (Pred/CsA/MMF) at the end of the 1st year;
2. More than one acute rejection episode;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Glomerular filtration rate;<br /><br>2. Incidence of acute rejections;<br /><br>3. Serumlipids;<br /><br>4. Bloodpressure and number of antihypertensive drugs.
- Secondary Outcome Measures
Name Time Method 1. Graft survival;<br /><br>2. Incidence of malignancies;<br /><br>3. Incidence of viral infections;<br /><br>4. Incidence of anemia.